https://nanets.net/abstracts-archive/2024?format=html Wed, 05 Feb 2025 00:00:00 -0500 en-GB hourly 1 https://nanets.net/abstracts-archive/2024/2085-b1-yi-development-of-innovative-in-vitro-and-in-vivo-patient-derived-cancer-models-for-translational-studies-in-g1-g2-gastroenteropancreatic-neuroendocrine-tumors?format=html [B1] Poster - Yi - Development of innovative in vitro and in vivo patient-derived cancer models for translational studies in G1/G2 gastroenteropancreatic neuroendocrine tumors https://nanets.net/abstracts-archive/2024/2085-b1-yi-development-of-innovative-in-vitro-and-in-vivo-patient-derived-cancer-models-for-translational-studies-in-g1-g2-gastroenteropancreatic-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2086-b16-mohamed-comparison-of-pulmonary-versus-extra-pulmonary-small-cell-neuroendocrine-carcinomas-demonstrate-distinct-genomic-alterations-1?format=html [B16] Poster - Mohamed - Comparison of pulmonary versus extra-pulmonary small cell neuroendocrine carcinomas demonstrate distinct genomic alterations https://nanets.net/abstracts-archive/2024/2086-b16-mohamed-comparison-of-pulmonary-versus-extra-pulmonary-small-cell-neuroendocrine-carcinomas-demonstrate-distinct-genomic-alterations-1?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2087-b17-mohamed-molecular-landscape-of-extra-pulmonary-small-cell-neuroendocrine-carcinomas-based-on-site-of-origin-1?format=html [B17] Poster - Mohamed - Molecular landscape of extra-pulmonary small cell neuroendocrine carcinomas based on site of origin https://nanets.net/abstracts-archive/2024/2087-b17-mohamed-molecular-landscape-of-extra-pulmonary-small-cell-neuroendocrine-carcinomas-based-on-site-of-origin-1?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2088-b18-mohamed-uncovering-genomic-differences-between-small-and-large-cell-extra-pulmonary-neuroendocrine-carcinomas-1?format=html [B18] Poster - Mohamed - Uncovering genomic differences between small and large cell extra-pulmonary neuroendocrine carcinomas https://nanets.net/abstracts-archive/2024/2088-b18-mohamed-uncovering-genomic-differences-between-small-and-large-cell-extra-pulmonary-neuroendocrine-carcinomas-1?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2089-c1-mohamed-np-101-in-combination-with-nivolumab-and-ipilimumab-in-metastatic-extra-pulmonary-neuroendocrine-carcinomas-ep-necs-a-pilot-study?format=html [C1] Poster - Mohamed - NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A PIlot Study https://nanets.net/abstracts-archive/2024/2089-c1-mohamed-np-101-in-combination-with-nivolumab-and-ipilimumab-in-metastatic-extra-pulmonary-neuroendocrine-carcinomas-ep-necs-a-pilot-study?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2090-c7-poster-schnell-cabozantinib-therapy-in-patients-with-previously-treated-well-differentiated-grade-3-neuroendocrine-tumors-g3-nets?format=html [C7] Poster - Schnell - Cabozantinib therapy in patients with previously treated well differentiated grade 3 neuroendocrine tumors (G3 NETs) https://nanets.net/abstracts-archive/2024/2090-c7-poster-schnell-cabozantinib-therapy-in-patients-with-previously-treated-well-differentiated-grade-3-neuroendocrine-tumors-g3-nets?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2091-c9-poster-halfdanarson-cabozantinib-versus-placebo-for-advanced-neuroendocrine-tumors-after-progression-on-prior-therapy-cabinet-trial-alliance-a021602?format=html [C9] Poster - Halfdanarson - Cabozantinib Versus Placebo for Advanced Neuroendocrine Tumors after Progression on Prior Therapy (CABINET Trial/Alliance A021602) https://nanets.net/abstracts-archive/2024/2091-c9-poster-halfdanarson-cabozantinib-versus-placebo-for-advanced-neuroendocrine-tumors-after-progression-on-prior-therapy-cabinet-trial-alliance-a021602?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2092-c13-poster-mulla-patterns-of-long-term-remission-or-apparent-cure-in-a-cohort-of-patients-with-grade-3-neuroendocrine-neoplasms-nens?format=html [C13] Poster - Mulla - Patterns of long-term remission or apparent cure in a cohort of patients with grade 3 neuroendocrine neoplasms (NENs) https://nanets.net/abstracts-archive/2024/2092-c13-poster-mulla-patterns-of-long-term-remission-or-apparent-cure-in-a-cohort-of-patients-with-grade-3-neuroendocrine-neoplasms-nens?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2093-c19-poster-mosalem-safety-of-lutetium-177-dotatate-treatment-in-patients-with-advanced-neuroendocrine-tumors-and-extensive-innumerable-bone-metastases?format=html [C19] Poster - Mosalem - Safety of Lutetium-177 DOTATATE Treatment in Patients with Advanced Neuroendocrine Tumors and Extensive/Innumerable Bone Metastases https://nanets.net/abstracts-archive/2024/2093-c19-poster-mosalem-safety-of-lutetium-177-dotatate-treatment-in-patients-with-advanced-neuroendocrine-tumors-and-extensive-innumerable-bone-metastases?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2094-c38-poster-schnell-radioactivity-in-drained-body-cavity-fluid-following-peptide-receptor-radionuclide-therapy-with-177lu-dotatate-in-patients-with-advanced-neuroendocrine-tumors?format=html [C38] Poster - Schnell - Radioactivity in drained body cavity fluid following peptide receptor radionuclide therapy with 177Lu DOTATATE in patients with advanced neuroendocrine tumors https://nanets.net/abstracts-archive/2024/2094-c38-poster-schnell-radioactivity-in-drained-body-cavity-fluid-following-peptide-receptor-radionuclide-therapy-with-177lu-dotatate-in-patients-with-advanced-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2095-c45-poster-nkie-interaction-between-race-and-insurance-coverage-for-gastroenteropancreatic-neuroendocrine-tumor-outcomes?format=html [C45] Poster - Nkie - Interaction Between Race and Insurance Coverage for Gastroenteropancreatic Neuroendocrine Tumor Outcomes https://nanets.net/abstracts-archive/2024/2095-c45-poster-nkie-interaction-between-race-and-insurance-coverage-for-gastroenteropancreatic-neuroendocrine-tumor-outcomes?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2096-c47-poster-slaby-response-after-neoadjuvant-therapy-for-pancreatic-neuroendocrine-tumors?format=html [C47] Poster - Slaby - Response After Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors https://nanets.net/abstracts-archive/2024/2096-c47-poster-slaby-response-after-neoadjuvant-therapy-for-pancreatic-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2097-c8-poster-mosalem-temozolomide-induced-hypermutation-in-pancreatic-neuroendocrine-tumors-a-case-series?format=html [C8] Poster - Mosalem - Temozolomide Induced Hypermutation in Pancreatic Neuroendocrine Tumors: A Case Series https://nanets.net/abstracts-archive/2024/2097-c8-poster-mosalem-temozolomide-induced-hypermutation-in-pancreatic-neuroendocrine-tumors-a-case-series?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2098-b5-makinen-single-nucleus-transcriptome-profiling-of-enterochromaffin-cells-in-si-net-patients?format=html [B5] Makinen - Single-nucleus transcriptome profiling of enterochromaffin cells in SI-NET patients https://nanets.net/abstracts-archive/2024/2098-b5-makinen-single-nucleus-transcriptome-profiling-of-enterochromaffin-cells-in-si-net-patients?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Wed, 05 Feb 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2075-o1-poster-hall-hereditary-and-clinical-insights-into-paraganglioma-and-pheochromocytoma?format=html [O1] Poster - Hall - Hereditary and Clinical Insights into Paraganglioma and Pheochromocytoma https://nanets.net/abstracts-archive/2024/2075-o1-poster-hall-hereditary-and-clinical-insights-into-paraganglioma-and-pheochromocytoma?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Fri, 03 Jan 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2076-o4-poster-gujarathi-men1-daxx-alterations-are-associated-with-improved-overall-survival-and-treatment-response-in-patients-with-pancreatic-neuroendocrine-tumors?format=html [O4] Poster - Gujarathi - MEN1 / DAXX alterations are associated with improved overall survival and treatment response in patients with pancreatic neuroendocrine tumors https://nanets.net/abstracts-archive/2024/2076-o4-poster-gujarathi-men1-daxx-alterations-are-associated-with-improved-overall-survival-and-treatment-response-in-patients-with-pancreatic-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Fri, 03 Jan 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2077-o5-poster-gujarathi-peptide-receptor-radionuclide-therapy-versus-capecitabine-temozolomide-for-the-treatment-of-metastatic-pancreatic-neuroendocrine-tumors?format=html [O5] Poster - Gujarathi - Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the treatment of Metastatic Pancreatic Neuroendocrine Tumors https://nanets.net/abstracts-archive/2024/2077-o5-poster-gujarathi-peptide-receptor-radionuclide-therapy-versus-capecitabine-temozolomide-for-the-treatment-of-metastatic-pancreatic-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Fri, 03 Jan 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2078-p1-poster-antwi-rare-germline-variants-in-men1-tsc1-atm-and-msh2-are-associated-with-higher-risk-for-pancreatic-neuroendocrine-tumors?format=html [P1] Poster - Antwi - Rare germline variants in MEN1, TSC1, ATM, and MSH2 are associated with higher risk for pancreatic neuroendocrine tumors https://nanets.net/abstracts-archive/2024/2078-p1-poster-antwi-rare-germline-variants-in-men1-tsc1-atm-and-msh2-are-associated-with-higher-risk-for-pancreatic-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Fri, 03 Jan 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2079-o11-poster-laffan-health-related-quality-of-life-issues-in-patients-with-non-metastatic-neuroendocrine-neoplasms-persist-after-treatment?format=html [O11] Poster - Laffan - Health - related quality of life issues in patients with non - metastatic neuroendocrine neoplasms persist after treatment https://nanets.net/abstracts-archive/2024/2079-o11-poster-laffan-health-related-quality-of-life-issues-in-patients-with-non-metastatic-neuroendocrine-neoplasms-persist-after-treatment?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Fri, 03 Jan 2025 00:00:00 -0500 https://nanets.net/abstracts-archive/2024/2080-p4-poster-dureja-think-nens-global-educational-program-on-neuroendocrine-neoplasms-diagnostics-and-management-for-primary-care-physicians?format=html [P4] Poster - Dureja - Think NENs Global Educational Program on Neuroendocrine Neoplasms Diagnostics and Management for Primary Care Physicians https://nanets.net/abstracts-archive/2024/2080-p4-poster-dureja-think-nens-global-educational-program-on-neuroendocrine-neoplasms-diagnostics-and-management-for-primary-care-physicians?format=html wertherm@adgcommunications.com (Maureen Werther) 2024 Fri, 03 Jan 2025 00:00:00 -0500